AstraZeneca to discontinue Epanova trial, expects $100 mn writedown
The drug is already approved in the United States to reduce high levels of triglyceride in adult patients
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.